Advertisement

Topics

PharmaMar presents positive results from a Phase II study of PM1183 in Ewing's sarcoma

19:00 EST 12 Nov 2017 | AAAS

(Pharmamar) PharmaMar (MSE:PHM) has presented positive results from a Phase II study of lurbinectedin in Ewing´s sarcoma at the Connective Tissue Oncology Society´s (CTOS) International Congress that took place in Hawaii from the 8th to the 11th of November.

Original Article: PharmaMar presents positive results from a Phase II study of PM1183 in Ewing's sarcoma

NEXT ARTICLE

More From BioPortfolio on "PharmaMar presents positive results from a Phase II study of PM1183 in Ewing's sarcoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...